Dixon Hubard Feinour & Brown’s ICU Medical ICUI Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,740	Closed	-$2.81M	–	182
2019 Q1	$2.81M	Sell	11,740 -690	-6%	-$165K	0.85%	35
2018 Q4	$2.85M	Sell	12,430 -840	-6%	-$207K	1.06%	31
2018 Q3	$3.75M	Sell	13,270 -740	-5%	-$217K	1.04%	32
2018 Q2	$4.11M	Sell	14,010 -275	-2%	-$75.2K	1.2%	31
2018 Q1	$3.61M	Sell	14,285 -585	-4%	-$137K	1.01%	32
2017 Q4	$3.21M	Sell	14,870 -125	-0.8%	-$25.3K	0.87%	35
2017 Q3	$2.79M	Buy	14,995 +75	+0.5%	+$13.1K	0.8%	39
2017 Q2	$2.57M	Buy	14,920 +11,195	+301%	+$1.8M	0.74%	41
2017 Q1	$569K	Buy	3,725 +300	+9%	+$43.8K	0.17%	108
2016 Q4	$505K	Buy	+3,425	New	+$496K	0.16%	115

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Dixon Hubard Feinour & Brown's ICUI Position: Q2 2019 in Review

Dixon Hubard Feinour & Brown sold out of ICU Medical (ICUI) in Q2 2019, closing a stake of 11,740 shares — an estimated $2.81M sold.

Dixon Hubard Feinour & Brown first reported a position in ICUI in Q4 2016 and held it in 10 quarters. The position peaked at $4.11M in Q2 2018. 270 funds tracked by Wall St. Rank hold ICUI as of Q2 2019.

Dixon Hubard Feinour & Brown reported no remaining ICU Medical position as of Q2 2019 after selling out during the quarter.
Dixon Hubard Feinour & Brown sold 11,740 ICU Medical shares in Q2 2019, an estimated $2.81M.
Dixon Hubard Feinour & Brown first reported a position in ICU Medical in Q4 2016 and held it in 10 quarters.
Dixon Hubard Feinour & Brown's ICU Medical position peaked at $4.11M in Q2 2018.
270 funds tracked by Wall St. Rank held ICU Medical as of Q2 2019.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2019, filed 14 Aug 2019.